Charles Schwab Investment Management Inc Forma Therapeutics Holdings, Inc. Transaction History

Charles Schwab Investment Management Inc

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$7.12 - $20.24 $250,239 - $711,355	35,146 Added 14.71%	274,027 $5.47 Million
Q2 2022 Aug 15, 2022	BUY	$5.1 - $10.0 $96,808 - $189,820	18,982 Added 8.63%	238,881 $1.65 Million
Q1 2022 May 13, 2022	SELL	$8.34 - $14.69 $70,839 - $124,776	-8,494 Reduced 3.72%	219,899 $2.05 Million
Q4 2021 Feb 11, 2022	BUY	$13.6 - $24.89 $38,515 - $70,488	2,832 Added 1.26%	228,393 $3.25 Million
Q3 2021 Nov 16, 2021	BUY	$21.22 - $25.7 $1.28 Million - $1.55 Million	60,228 Added 36.43%	225,561 $5.23 Million
Q2 2021 Aug 16, 2021	BUY	$22.86 - $30.95 $179,016 - $242,369	7,831 Added 4.97%	165,333 $4.12 Million
Q1 2021 May 17, 2021	BUY	$24.58 - $42.82 $762,619 - $1.33 Million	31,026 Added 24.53%	157,502 $4.41 Million
Q4 2020 Feb 16, 2021	BUY	$34.9 - $51.08 $963,554 - $1.41 Million	27,609 Added 27.93%	126,476 $4.42 Million
Q3 2020 Nov 13, 2020	BUY	$32.95 - $50.25 $3.26 Million - $4.97 Million	98,867 New	98,867 $4.93 Million

26.5K

Ticker FMTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,860,400
Market Cap $958M
Description
Forma Therapeutics Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on development and commercialization of novel therapeutics for treatment of rare hematologic diseases and cancers. Its core product candidates for development include FT-4202, which is Phase 1 trial for the treatment of sickle cell disease and other hemoglobin...

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

Stay updated on Charles Schwab Investment Management Inc with notifications on news.